Transition from IV to subcutaneous insulin

Transition Criteria - Green Light for the Switch

Before discontinuing the insulin drip, ensure the patient meets all criteria, signaling DKA resolution.

• Metabolic Control:
  • Blood Glucose: <200 mg/dL
  • Anion Gap: ≤12 mEq/L
  • Serum Bicarbonate: ≥15 mEq/L
• Patient Status:
  • Tolerating oral intake

⭐ Crucial Overlap: Continue IV insulin for 1-2 hours after the first subcutaneous basal insulin dose. Abruptly stopping the drip before subcutaneous insulin takes effect can cause a rapid return to hyperglycemia and ketoacidosis.

The Insulin Hand-Off - Bridging the Gap

To prevent rebound hyperglycemia and ketosis, a crucial overlap is required when switching from IV to subcutaneous (SC) insulin. The short half-life of IV insulin means stopping it before SC insulin acts creates a dangerous gap in coverage.

• Core Principle: Bridge the gap between IV insulin's short half-life and the onset of SC long-acting insulin.
• Action: Administer SC basal insulin (glargine, detemir) 1-2 hours before stopping the IV infusion.
• ⚠️ Pitfall: Prematurely stopping the IV drip leads to rebound hyperglycemia and ketosis.

⭐ A common starting point for the daily basal insulin dose is 50-60% of the total insulin given in the previous 24 hours, divided between basal and prandial insulin.

Sub-Q Dosing - The Insulin Math

• Calculate Total Daily Dose (TDD):
  • Weight-Based (Insulin Naive): Start with 0.5-0.8 U/kg/day.
  • Infusion-Based (Preferred): Use 80% of the total IV insulin infused over the preceding 24 hours.
    • $TDD = (Total , IV , insulin , in , 24h) \times 0.8$
• Split the TDD:
  • Basal Insulin: 50% of TDD (e.g., Glargine, Detemir) given once daily.
  • Prandial Insulin: 50% of TDD divided among meals (e.g., Lispro, Aspart).
• Correction Factor: Add supplemental rapid-acting insulin for pre-meal hyperglycemia.

⭐ Overlap is Key: Administer the first dose of long-acting subcutaneous insulin 1-2 hours before discontinuing the IV insulin infusion to ensure continuous coverage and prevent a gap.

High‑Yield Points - ⚡ Biggest Takeaways

• Overlap is critical: Administer SC long-acting insulin 1-2 hours before stopping the IV insulin infusion to prevent rebound hyperglycemia.
• IV insulin's short half-life is the primary reason for the required overlap period.
• The patient must be able to tolerate oral intake before making the switch.
• Key metabolic goals for transition: anion gap ≤12 mEq/L, bicarbonate ≥15 mEq/L, and blood glucose <200 mg/dL.
• Initiate a basal-bolus regimen with both long-acting and rapid-acting insulin.